CAS: 147739-88-6; 6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine

该化合物是双环有机化合物,其特点是其引信的火花和环.该化合物在两个环中都有氮原子,有助于其基本性和潜在反应性.它一般看起来无色,可视其形态和纯度,淡黄色液体或固态为灰色.二氢化合物组的存在表明,它有两种氢原子添加到环中,可影响其化学特性,例如溶液性和稳定性.该化合物对医药化学具有兴趣,因为它具有潜在的生物活动,包括与各种受体和酶的相互作用.其结构允许多种功能化,使其成为有机合成的多功能性中间体.此外,该化合物独特的环系统可能具有特定的药理特性,成为药物开发进一步研究的候选物.处理和储存安全数据,如同任何化学物质一样,应当用于处理和储存.

结构式图片

相似化合物

147740-02-1 651558-51-9 204593-51-1

上下游产品

CAS号109966-30-5 6-苄基-6,7-二氢-5H-... | CAS号45754-12-9 2,3-双(氯甲基)吡啶 | CAS号89-00-9 吡啶-2,3-二羧酸 | CAS号605-38-9 2,3-吡啶二甲酸二甲酯 | CAS号423169-40-8 2,3-吡啶二甲醇盐酸盐 | CAS号1059172-92-7 5H-吡咯并[3,4-b]吡啶... | CAS号186203-81-6 6-B°C-八氢吡咯并[3,4-b]吡啶 | CAS号1141669-88-6 6-乙基八氢吡咯并[3,4-B]吡啶

合成工艺路线路线简述

    📜2,3-双(氯甲基)吡啶置于邻,对甲苯磺酰胺,Sodium Hydride体系中,用 N,N-二甲基甲酰胺 用作溶剂,以46%的收率获得6,7-二氢-5H-吡咯并[3,4-B]吡啶
    参考文献:A Robust Process For An Mglur5 Negative Allosteric Modulator: Difluoromethylation And Sonogashira Coupling On Large Scale
    标题:A Robust Process For An Mglur5 Negative Allosteric Modulator: Difluoromethylation And Sonogashira Coupling On Large Scale
    摘要:The Development Of The Potent And Selective Mglur5 Negative Allosteric Modulator (Nam) 1 Is Described. Key Features In The Process,Which Has Been Implemented On A Multikilogram Scale,Include A High-Temperature Difluoromethylation Reaction,A Sonogashira Coupling,And Careful Control Of Residual Pd And Cu In The Final Api. Due To The Relative Nonpolar Nature Of The Intermediates,Water-Miscible Solvents Were Employed In All Four Steps To Allow For Direct Crystallizations Upon Reaction Completion. In Addition,Several Crystalline Morphologies Of The Api Were Discovered,And The Isolation Of The Desired Form Ii Will Be Discussed.
    Doi:10.1021/op3002728

    海关参考信息

    专利信息


    专利号:US-12336981-B2
    优先权日:2010-09-03
    标题 :Compounds and compositions for the inhibition of NAMPT
    发明人:BAIR KENNETH W; BAUMEISTER TIMM R; BUCKMELTER ALEXANDRE J; CLODFELTER KARL H; DRAGOVICH Peter; GOSSELIN FRANCIS; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; ROTH BRUCE; SMITH CHASE C; WANG ZHONGGUO; YUEN PO-WAI; ZHENG XIAOZHANG
    权利人:VALO HEALTH INC; GENENTECH INC
    摘要:The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:

    专利号:US-9169209-B2
    优先权日:2011-05-04
    标题:Compounds and compositions for the inhibition of NAMPT
    发明人:BAIR KENNETH W; BAUMEISTER TIMM; BUCKMELTER ALEXANDRE J; CLODFELTER KARL H; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; SMITH CHASE C; WANG ZHONGGUO; ZHENG XIAOZHANG
    权利人:BAIR KENNETH W; BAUMEISTER TIMM; BUCKMELTER ALEXANDRE J; CLODFELTER KARL H; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; SMITH CHASE C; WANG ZHONGGUO; ZHENG XIAOZHANG; FORMA TM LLC
    摘要:The present invention relates to compounds and composition for inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below.

    专利号:US-11312722-B2
    优先权日:2019-05-08
    标 题:Hsp90 inhibitors and uses thereof
    发明人:BROWN LAUREN ELAINE; HUANG DAVID S; COWEN LEAH E; WHITESELL LUKE; MARCYK PAUL
    权利人:UNIV BOSTON; GOVERNING COUNCIL UNIV TORONTO
    摘要:Herein is described the design and synthesis of resorcylate aminopyrazole compounds. These compounds show broad, potent and fungal-selective Hsp90 inhibitory activity. These compounds also find use in treating Hsp90 related diseases.

    专利号:US-8536164-B2
    优先权日:2010-12-20
    标 题:Fused pyridine compounds as casein kinase inhibitors
    发明人:BUTLER TODD W; CHANDRASEKARAN RAMALAKSHMI Y; MENTE SCOT R; SUBRAMANYAM CHAKRAPANI; WAGER TRAVIS T
    权利人:BUTLER TODD W; CHANDRASEKARAN RAMALAKSHMI Y; MENTE SCOT R; SUBRAMANYAM CHAKRAPANI; WAGER TRAVIS T; PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: n nand pharmaceutically acceptable salts thereof, wherein X, Y, A, R 4 , n, and R 7 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知